LYON, France, March 5, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today its successful participation at the Third International Workshop on Focal Therapy and Imaging of Prostate and Kidney Cancer, held February 24-27, 2010 in Washington, D.C. During the high-level workshop, EDAP organized a specific Symposium, included in the official program, dedicated to Ablatherm-HIFU focal therapy for localized prostate cancer.
